+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study)



Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study)



Health and Quality of Life Outcomes 17(1): 23



The daily diary Urticaria Activity Score (UAS) and its weekly score (UAS7) are widely used to assess signs and symptoms in patients with chronic spontaneous urticaria (CSU). The objective of this study was to assess the psychometric properties of a Spanish version of the once-daily UAS. Observational study in patients ≥18 years old receiving usual care for CSU (daily or almost daily occurrence of generalized hives or angioedema for ≥6 weeks). Patients were included consecutively and completed the UAS, EQ-5D, and the Chronic Urticaria Quality of Life scale (CU-Q2oL) at two study visits 6 weeks apart. On each occasion, the UAS was completed once-daily for 7 consecutive days to be able to calculate the UAS7 score. Psychometric properties of reliability, construct validity, and responsiveness were assessed. The Minimal Important Difference (MID) was estimated for the UAS7 using anchor- and distribution-based approaches. Data from 166 patients was available for analysis (mean age 49 years, 65.7% female). Floor (5.4% of patients with the lowest possible score) and ceiling (1.2%) effects were low; 15% of patients had missing values. Internal consistency and test-retest reliability were good (Cronbach's alpha of 0.83 and an ICC of 0.84, respectively). Convergent validity was demonstrated through the pattern of correlations with the EQ-5D and CU-Q2oL and known groups' validity was demonstrated by the instrument's ability to discriminate between patients with different overall levels of urticaria severity, with between-group effect-sizes (ES) ranging from 0.36 to 1.19. The UAS7 proved responsive to change with effect sizes ranging from 0.3 to 1.52 in patients reporting improvement or deterioration in overall urticaria status. The MID for the UAS7 score was estimated at 7-8 points, on a scale of 0-42. The Spanish version of the UAS score has demonstrated a robust psychometric performance in patients with CSU managed in conditions of usual care. It can therefore be considered a suitable instrument to assess disease activity in clinical practice in Spanish-speaking patients. The Spanish version's reliability and validity are similar to those reported for other language versions of the once- and twice-daily variants of the UAS.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066446627

Download citation: RISBibTeXText

PMID: 30704532

DOI: 10.1186/s12955-019-1087-z


Related references

The Urticaria Control Test and Urticaria Activity Score correlate with quality of life in adult Japanese patients with chronic spontaneous urticaria. Allergology International 2018, 2018

The persistence of chronic spontaneous urticaria in childhood is associated with the urticaria activity score. Allergy and Asthma Proceedings 38(2): 136-142, 2017

Categorical Health States In Chronic Spontaneous Urticaria (Csu) Based On The Weekly Urticaria Activity Score (Uas7): Are They Distinct, Discriminative, And Reproducible?. Value in Health 17(7): A611, 2014

Chronic Inducible Urticaria (CIndU) versus Chronic Spontaneous Urticaria (CSU): Can new names and new updated information improve our care for patients with urticaria?. Asian Pacific Journal of Allergy and Immunology 34(2): 95-97, 2017

Assessment of Qol by Urticaria Activity Score in Pediatric Patients with Chronic Urticaria. Arerugi 65(1): 41-47, 2016

Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria. Annals of Allergy, Asthma and Immunology 108(1): 20-24, 2012

Validation of The Spanish Version of The Urticaria Activity Score (Uas) and Its Use Over One Week (Uas7). Value in Health 18(7): A426, 2015

Validation of the Turkish version of the Urticaria Control Test: Correlation with other tools and comparison between spontaneous and inducible chronic urticaria. World Allergy Organization Journal 12(1): 100009, 2019

Omalizumab for the treatment of chronic spontaneous urticaria in daily clinical practice in South Spain. Dermatologic Therapy 31(5): E12669, 2018

The clinical and laboratory characteristics of acute spontaneous urticaria and its progression to chronic spontaneous urticaria. Allergy and Asthma Proceedings 37(5): 394-399, 2017

Clinical management of urticaria using omalizumab: the first licensed biological therapy available for chronic spontaneous urticaria. Journal of the European Academy of Dermatology and Venereology 30(Suppl. 5): 25-32, 2017

Prevalence of Inducible Urticaria in Patients with Chronic Spontaneous Urticaria: Associated Risk Factors. Journal of Allergy and Clinical Immunology. in Practice 5(2): 464-470, 2016

Investigation of thiol-disulphide balance in patients with acute urticaria and chronic spontaneous urticaria. Cutaneous and Ocular Toxicology 36(3): 205-210, 2016

Thyroid Autoimmunity and Autoimmunity in Chronic Spontaneous Urticaria Linked to Disease Severity, Therapeutic Response, and Time to Remission in Patients with Chronic Spontaneous Urticaria. Biomed Research International 2018: 9856843, 2019

Demonstrating measurement equivalence of the electronic and paper formats of the Urticaria Patient Daily Diary in patients with chronic idiopathic urticaria. Patient 6(3): 225-231, 2013